Amgen’s Blincyto wins full US approval

13th July 2017 Uncategorised 0

Amgen’s Blincyto has been issued a full approval in the US as a treatment for adults and children with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (ALL).

More: Amgen’s Blincyto wins full US approval
Source: News